Parexel 被 EQT Private Equity 及 Goldman Sachs Asset Management 收購
July 06, 2021 14:52 ET
|
Parexel International LLC
波士頓及北卡羅來納州達勒姆, July 07, 2021 (GLOBE NEWSWIRE) -- Parexel 是一家領先的全球臨床研究組織，專注開發和提供創新的新療法以促進患者健康，今天宣佈執行最終合併協議，公司將被 EQT IX 基金（「EQT Private Equity」）以及 Pamplona Capital Management LP 旗下的 Goldman Sachs...
Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management
July 02, 2021 10:33 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Introduces Discussions on Diversity Research to Promote Diversity in Clinical Trials
May 20, 2021 07:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., May 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the release of “Discussions on Diversity,” an in-depth...
Parexel Recognized as Most Favored Provider in ISR CRO Phase I Quality Benchmarking Report
May 13, 2021 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Achieves Top Rankings in Industry Across Multiple Attributes in ISR CRO Phase II-III Benchmarking Report
May 04, 2021 09:00 ET
|
Parexel International LLC
BOSTON and Durham, N.C., May 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
February 04, 2021 07:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C. and FT. MYERS, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve...
Parexel and Signify Health Collaborating to Develop New Solutions to Promote Access and Inclusion in Clinical Trials
January 13, 2021 09:00 ET
|
Parexel International LLC
Companies partnering to reduce social determinants of health barriers to clinical trial enrollment BOSTON, DURHAM, N.C. and DALLAS, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Parexel and Signify Health...
Parexel Completes Separation of Parexel Informatics and Medical Imaging Business
January 11, 2021 06:00 ET
|
Parexel International LLC
Strategic move enhances value and growth for both companiesParexel Informatics to relaunch as Calyx BOSTON and DURHAM, N.C., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of...
Parexel Names Clare Grace to Newly-Created Role of Chief Patient Officer
January 04, 2021 10:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Joins Decentralized Trials & Research Alliance (DTRA) to Enhance Patient Access, Increase Diversity and Accelerate Trial Timelines
December 14, 2020 12:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...